CD4 and neoplasm: In the tumor immune microenvironment of STAD patients with a high PRG score and poorer prognosis, we observed significantly lower levels of CD4+ T cells and neutrophils, as well as significantly higher levels of regulatory T cells compared to the other group, suggesting the presence of an immunosuppressive microenvironment in patients with poor prognosis.